Pirro F, Caldarola G, Bernardini N, Celeste MG, Dattola A, De Luca E, et al. Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in Italy. Dermatol Pract Concept [Internet]. 2025 Jan. 29 [cited 2026 Apr. 19];15(1):4838. Available from: https://mail.dpcj.org/index.php/dpc/article/view/4838